4d Molecular Therapeutics In shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $558k | 64k | 8.69 |
| 2025-06-30 | $245k | 66k | 3.71 |
| 2025-03-31 | $229k | 71k | 3.23 |
| 2024-12-31 | $409k | 73k | 5.57 |
| 2024-09-30 | $754k | 70k | 10.81 |
| 2024-06-30 | $1.5M | 73k | 20.99 |
| 2024-03-31 | $2.0M | 64k | 31.86 |
| 2023-12-31 | $1.2M | 60k | 20.26 |
| 2023-09-30 | $744k | 58k | 12.73 |
| 2023-06-30 | $885k | 49k | 18.07 |
| 2023-03-31 | $817k | 48k | 17.20 |
| 2022-12-31 | $1.1M | 47k | 22.22 |
| 2022-09-30 | $365k | 45k | 8.04 |
| 2022-06-30 | $290k | 42k | 6.97 |
| 2022-03-31 | $531k | 35k | 15.13 |
| 2021-12-31 | $674k | 31k | 21.94 |
| 2021-09-30 | $662k | 25k | 26.98 |
| 2021-06-30 | $229k | 9.5k | 24.09 |
| 2021-03-31 | $254k | 5.9k | 43.37 |